CHI3L1 and Tako-tsubo cardiomyopathy: In particular, ASC patients with high serological levels of YKL-40 (≥75 ng/mL) were associated with a worse 5-year survival rate (70.2%) compared to ASC patients with low YKL-40 serum level (85.3%; p = 0.038).